Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stavudine ER vs IR in HIV
NCT00005918Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2000
- Primary completion
- Apr 2002
- Modality
- Small Molecules
- Countries
- 16
01
Overview
Phase 3, randomised, double-blind trial of stavudine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Bristol Myers Squibb. Started Jun 2000; status: completed.
02
Drugs
stavudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00005918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005918.